PFG Private Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

PFG Private Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,219	Closed	-$336K	–	62
2020 Q4	$336K	Sell	2,219 -224	-9%	-$32K	0.26%	38
2020 Q3	$331K	Buy	2,443 +38	+2%	+$5.16K	0.29%	37
2020 Q2	$329K	Buy	+2,405	New	+$307K	0.31%	37

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PFG Private Wealth Management's IBB Position: Q1 2021 in Review

PFG Private Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 2,219 shares — an estimated $336K sold.

PFG Private Wealth Management first reported a position in IBB in Q2 2020 and held it in 3 quarters. The position peaked at $336K in Q4 2020. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

PFG Private Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
PFG Private Wealth Management sold 2,219 iShares Biotechnology ETF shares in Q1 2021, an estimated $336K.
PFG Private Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 3 quarters.
PFG Private Wealth Management's iShares Biotechnology ETF position peaked at $336K in Q4 2020.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on PFG Private Wealth Management's 13F filing for Q1 2021, filed 7 May 2021.